Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery - Trial NCT06213805
Access comprehensive clinical trial information for NCT06213805 through Pure Global AI's free database. This phase not specified trial is sponsored by Hôpital Privé de la Baie and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 23 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hôpital Privé de la Baie
Timeline & Enrollment
N/A
Jan 15, 2024
Feb 28, 2026
Primary Outcome
Measurement of intraocular pressure by tonometry
Summary
The main objective is to evaluate the effectiveness of MIMS in patients with an indication
 for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess
 safety. The investigating ophthalmologist will follow the patients and collect clinical data
 in order to identify the benefits and complications of MIMS. Patients are expected to
 experience fewer complications compared to traditional glaucoma surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06213805
Non-Device Trial